PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
Not Just a Movement Disorder: Cognitive Changes in PD
By Laura Marsh, M.D.
Distractibility, disorganization, forgetfulness, and difficulties with planning: it frequently comes as a surprise to people with Parkinson’s disease (PD) and their families that “cognitive changes” — alterations in memory, attention, and thinking — are often part of PD. After all, in 1817, when James Parkinson first described the “shaking palsy” he said that, “the senses and intellect were uninjured.” While he was correct in most of his assertions, Dr. Parkinson did miss the mark with this claim.
Cognitive changes can impact people’s everyday lives as much, and sometimes more than, the physical effects of PD. While physicians are increasingly recognizing the importance of addressing cognitive and other nonmotor symptoms, many still primarily focus on treating physical (motor) symptoms. This means that cognitive changes may go under-treated or untreated. It is critical that we, as physicians, understand how to prevent and treat cognitive difficulties. It is equally crucial that people with PD and their families understand what types of changes to look for in order to communicate concerns to their physicians. Increased awareness and treatment of cognitive difficulties can lead to improved quality of life for people with PD and their families.
Prevalence and Forms of Cognitive Changes in PD
‘Cognition’ is a general term used to refer to the various mental abilities involved in processing and using information. Examples include memory, attention, abstract thinking, problem-solving, language, and visual-perceptual abilities.
Nearly every person with PD experiences some degree of cognitive change, which can range from mild to severe. The terms, ‘mild cognitive impairment’ (MCI) and ‘cognitive impairment’ are generally used when changes are not severe and affect fairly narrow aspects of memory or thinking abilities. Some people who experience cognitive impairment may merely note that changes in mental abilities are a nuisance, while others report symptoms noticeable enough to affect performance at work or in managing things at home.
‘Dementia,’ a different classification altogether, is used to describe more extensive difficulties that affect multiple areas of cognitive function. People living with Parkinson’s with dementia (PD-D) may be unable to live independently, even if their physical symptoms are not advanced. In general, large-scale population-based studies show that PD-D usually develops many years after the initial onset of PD. When a dementia syndrome develops before or concurrently with PD motor signs, this is diagnosed as dementia with Lewy Bodies (DLB).
Cognitive impairment, in its varying degrees, affects the majority of individuals who have PD, while dementia is estimated to affect only one-third. The exact prevalence is unclear since there is not currently a single established measurement system for diagnosing cognitive impairment or PD-D.
If someone experiences mild cognitive impairment or cognitive impairment early in PD, is this any indication that they may develop dementia in the future? The evidence is mixed. Some research suggests that early cognitive impairment represents the initial stages of progression to dementia. However, other studies suggest the opposite. For example, studies show that people with PD without dementia, when compared to those with PD-D, experience cognitive impairments very differently.
Types of Cognitive Difficulties in PD
PD affects a variety of cognitive functions. Problems with executive function are often regarded as the most common. However, some people may undergo memory problems more significantly, while others will experience a mixture of difficulties. Most people retain their general intellectual abilities and knowledge as well as the short and long-term memories they acquired prior to the onset of PD.
Executive dysfunction: Executive functions are higher-order mental processes such as problem-solving and planning, initiating and following through on tasks, and multi-tasking ideas or projects. For a person with PD, paying bills or even taking part in group conversations can be difficult. Why? Because these activities require a person to be flexible and be able to shift from one category of information or one specific goal to another. People with PD may describe getting overwhelmed or ‘freezing’ in situations that require the formulation of a series of strategic choices, yet they appear to function perfectly when someone else helps them initiate and persist with a task. In the absence of some sort of “intellectual scaffolding,” it is more efficient for the person with PD to focus on one goal or concept at a time. An example is a person who was unable to initiate a project to clean his messy basement, but who successfully completed the task after his wife provided structure and cues by breaking down the task into parts and providing explicit instructions that focused on one single area at a time.
Memory disturbances: Remembering information that has already been learned is the most common difficulty for those with PD and can be improved through use of memory cues. For a person with PD to effectively learn and retain new information, repetition may be needed. PD-D affects both short-term and long-term memory functions more severely.
Attention difficulties: As the complexity of a situation increases, it can be difficult for a person with PD to maintain his or her focus or divide his or her attention. For example, patients may find they can no longer “walk and chew gum at the same time.” This affects intellectual pursuits and everyday activities such as walking, maintaining balance, and carrying on a conversation.
Bradyphrenia (slowed mental processing): People with PD say that the disease affects how quickly they can process and respond to information. Slowness in information processing impacts both other cognitive processes (such as problem-solving and retrieving information) and daily activities (such as conversing).
Language dysfunction: The most common language-related difficulty for people with PD is word-finding. As a person’s PD progresses, he or she may also experience problems with naming or mis-naming, may have difficulty comprehending complex information, and may use more simplified and less spontaneous speech.
Visual-spatial disturbances: Trouble perceiving, processing, discriminating, and acting on visual information in the environment can affect daily life. For example, it may become difficult to navigate around the house or estimate distances when reaching for something, thereby increasing the risk of falls. In some cases, visual-spatial impairment in PD may also lead to visual misperceptions, or illusions.
Causes of Cognitive Changes in PD
Our understanding of the causes of cognitive changes in PD is incomplete. We do know that problems with cognition are related to the same underlying brain changes that result in motor symptoms — that is, premature death of nerve cells, changes in brain neurochemistry, and subsequent alterations in brain circuitry between different brain regions. In addition, Lewy bodies, the abnormal collections of proteins that are found in nerve cells in PD, are related to changes in motor pathways and to pathways affecting cognitive processes.
Other elements can cause and aggravate cognitive difficulties. Untreated depression, anxiety, psychosis, sleep, and other behavioral difficulties can exacerbate cognitive difficulties. In addition, some medications, whether for PD or other conditions, can cause negative cognitive effects as can some non-PD-related general medical conditions, such as infections.
Treatment of Cognitive Changes in PD
The basis of all effective treatment is a thorough diagnostic evaluation. When an initial history is taken, by a primary care physician or a neurologist, it is important for a person with PD (and his or her caregiver) to bring up any observations or concerns about cognitive changes. Referral to a neurologist, neuropsychiatrist, or geriatric psychiatrist who specializes in the treatment of cognitive problems or dementia can be helpful. Additional tests may also be conducted to ascertain if a person’s difficulties are due to PD or to other reversible causes. Once other causes are excluded, a neuropsychological exam, involving paper-and-pencil tests, will be performed by a neuropsychologist to characterize the quality and extent of problems and to identify areas of strength.
Treatments for cognitive changes aim to reduce symptoms or improve daily life through using compensatory strategies (that is, coping mechanisms that help a person adapt to his or her cognitive limitations). For instance, clocks or timers may help a person remember when to take medication, and devices such as planners or voice recorders may help him or her recall an appointment.
Occupational therapists can also assist, by providing insights into how cognitive difficulties impact daily life, suggesting adaptive strategies, or providing formal treatment programs. Speech therapists can help with language functions and information processing.
Medications used to treat cognitive dysfunction in Parkinson’s are largely based on treatments used for Alzheimer’s disease and are usually reserved for these patients who already have dementia. At present, rivastigmine (Exelon®) is the only medication approved by the US Food and Drug Administration for the treatment of dementia in PD. Further research is needed to identify treatments that can help those who experience less severe cognitive impairments that occur earlier in the course of PD.
Cognitive changes are present to some degree in almost every person with PD and are a prominent feature of PD over its course. Although they have received less attention than motor symptoms, cognitive changes have obvious effects on daily life, including how people adapt to their motor symptoms. While we do not yet have definitive treatments for cognitive dysfunction in PD, recognition of what changes have occurred is important in order to take advantage of currently available medication and behavioral strategies.
Dr. Marsh is a geriatric psychiatrist, an Associate Professor of Psychiatry and Neurology at Johns Hopkins University School of Medicine, and director of the Clinical Research Program of the Johns Hopkins Morris K. Udall Parkinson’s Disease Research Center of Excellence. Her research focuses on neuropsychiatric aspects of PD.